These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1364848)

  • 21. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats.
    Mulvany MJ; Nyborg N
    Br J Pharmacol; 1980; 71(2):585-96. PubMed ID: 7470763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man.
    Lundberg JM; Terenius L; Hökfelt T; Goldstein M
    Neurosci Lett; 1983 Dec; 42(2):167-72. PubMed ID: 6689363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels.
    Edvinsson L; Ekblad E; Håkanson R; Wahlestedt C
    Br J Pharmacol; 1984 Oct; 83(2):519-25. PubMed ID: 6593107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional differences in the response to vasoconstrictor agents of dog and monkey isolated coronary arteries.
    Miwa K; Toda N
    Br J Pharmacol; 1984 May; 82(1):295-301. PubMed ID: 6587928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart.
    Gu J; Polak JM; Allen JM; Huang WM; Sheppard MN; Tatemoto K; Bloom SR
    J Histochem Cytochem; 1984 May; 32(5):467-72. PubMed ID: 6546942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide.
    Gu J; Polak JM; Adrian TE; Allen JM; Tatemoto K; Bloom SR
    Lancet; 1983 May; 1(8332):1008-10. PubMed ID: 6133058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.
    Lundberg JM; Hua XY; Franco-Cereceda A
    Acta Physiol Scand; 1984 Aug; 121(4):325-32. PubMed ID: 6091417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
    Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
    J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
    Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
    Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on cardiac distribution and function of neuropeptide Y.
    Allen JM; Gjörstrup P; Björkman JA; Ek L; Abrahamsson T; Bloom SR
    Acta Physiol Scand; 1986 Mar; 126(3):405-11. PubMed ID: 3754377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actions of neuropeptide Y on innervated and denervated rat tail arteries.
    Neild TO
    J Physiol; 1987 May; 386():19-30. PubMed ID: 3681705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
    Pernow J; Svenberg T; Lundberg JM
    Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent effects of neuropeptide Y and calcitonin gene-related peptide on human coronary vascular tone in vitro.
    Franco-Cereceda A; Lundberg JM
    Acta Physiol Scand; 1987 Sep; 131(1):159-60. PubMed ID: 3499753
    [No Abstract]   [Full Text] [Related]  

  • 35. Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries.
    Nyborg NC; Baandrup U; Mikkelsen EO; Mulvany MJ
    Pflugers Arch; 1987 Dec; 410(6):664-70. PubMed ID: 3449802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
    Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
    Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y induces potent contraction of arterial vascular smooth muscle via an endothelium-independent mechanism.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1988 Sep; 134(1):157-8. PubMed ID: 3239419
    [No Abstract]   [Full Text] [Related]  

  • 38. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptide Y modulates adrenergic neurotransmission by an endothelium dependent mechanism.
    Daly RN; Hieble JP
    Eur J Pharmacol; 1987 Jun; 138(3):445-6. PubMed ID: 3040443
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects.
    Rudehill A; Sollevi A; Franco-Cereceda A; Lundberg JM
    Peptides; 1986; 7(5):821-6. PubMed ID: 3025824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.